Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...

The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.

A new mental health and substance abuse treatment facility in Chambers County, Alabama faces opposition from the Birmingham-based Bradford Behavioral Health - a leading substance use disorder ("SUD") ...

University of Phoenix College of Doctoral Studies has released a new white paper, "Economic Influence of AI on Career Optimism," by Christine Marquis, MBA, and Marlene Blake, Ph.D., both fellows in ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...